Anwar MT, Adak AK, Kawade SK, Wu HR, Angata T, Lin CC.
Bioorg Med Chem. (2022 Aug)
Wu JL, Wu HY, Wu SJ, Tsai HY, Weng SH, Lin KT, Lin LI, Yao CY, Zamanova M, Lee YY, Angata T, Tien HF, Chen YJ, Lin KI.
Mol Cancer Res. (2022 Aug)
Anwar MT, Kawade SK, Huo YR, Adak AK, Sridharan D, Kuo YT, Fan CY, Wu HR, Lee YS, Angata T, Lin CC.
Eur J Med Chem. (2022 Mar)
Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells.
Chang LY, Liang SY, Lu SC, Tseng HC, Tsai HY, Tang CJ, Sugata M, Chen YJ, Chen YJ, Wu SJ, Lin KI, Khoo KH, Angata T.
Front Immunol. (2022 May)
Gebreyesus ST, Siyal AA, Kitata RB, Chen ES, Enkhbayar B, Angata T, Lin KI, Chen YJ, Tu HL.
Nat Commun. (2022 Jan)
Angata T, von Gunten S, Schnaar RL, Varki A. I-Type Lectins. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Mohnen D, Kinoshita T, Packer NH, Prestegard JH, Schnaar RL, Seeberger PH, editors.
Essentials of Glycobiology [Internet]. 4th ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press (2022)
[Review] Recent Progress in the Methodologies to Identify Physiological Ligands of Siglecs.
Jiang HS, Zhuang SC, Lam CH, Chang LY, Angata T.
Front Immunol. (2021 Dec)
Identification and functional characterization of a Siglec-7 counter- receptor on K562 cells.
Yoshimura A, Asahina Y, Chang LY, Angata T, Tanaka H, Kitajima K, Sato C.
J Biol Chem. (2021 Jan-Jun)
Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.
Hsu YW, Hsu FF, Chiang MT, Tsai DL, Li FA, Angata T, Crocker PR, Chau LY.
J Biomed Sci. (2021 Jan)
A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
Alborzian Deh Sheikh A, Gomaa S, Li X, Routledge M, Saigoh K, Numoto N, Angata T, Hitomi Y, Takematsu H, Tsuiji M, Ito N, Kusunoki S, Tsubata T.
J Autoimmun. (2021 Jan)
Preparation of Recombinant Siglecs and Identification of Their Ligands.
Chang LY, Low PY, Sridharan D, Gerlovin K, Angata T.
Methods Mol Biol. (2020)
[Review] Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases.
Angata T.
J Biomed Sci. (2020 Jan)
Liu CH, Raj S, Chen CH, Hung KH, Chou CT, Chen IH, Chien JT, Lin IY, Yang SY, Angata T, Tsai WC, Wei JC, Tzeng IS, Hung SC, Lin KI.
J Clin Invest. (2019 Dec)
Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC.
Eur J Med Chem. (2019 Oct)
Fan CY, Hou YR, Adak AK, Waniwan JT, Dela Rosa MAC, Low PY, Angata T, Hwang KC, Chen YJ, Lin CC.
Chem Sci. (2019 Aug)
Chemoenzymatic Synthesis of DSGb5 and Sialylated Globo-series Glycans.
Li PJ, Huang SY, Chiang PY, Fan CY, Guo LJ, Wu DY, Angata T, Lin CC.
Angew Chem Int Ed Engl. (2019 Aug)
[Review] Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
Angata T.
Front Immunol. (2018 Dec)
Huang PC , Low PY, Wang I, Hsu ST, Angata T.
J Biol Chem. (2018 Dec)
High affinity sugar ligands of C-type lectin receptor langerin.
Ota F, Hirayama T, Kizuka Y, Yamaguchi Y, Fujinawa R, Nagata M, Ismanto HS, Lepenies B, Aretz J, Rademacher C, Seeberger PH, Angata T, Kitazume S, Yoshida K, Betsuyaku T, Kida K, Yamasaki S, Taniguchi N.
Biochim Biophys Acta Gen Subj. (2018 Jul)
O-GlcNAcylation is required for B cell homeostasis and antibody responses.
Wu JL, Chiang MF, Hsu PH, Tsai DY, Hung KH, Wang YH, Angata T, Lin KI.
Nat Commun. (2017 Nov)
Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates.
Hayakawa T, Khedri Z, Schwarz F, Landig C, Liang SY, Yu H, Chen X, Fujito NT, Satta Y, Varki A, Angata T.
BMC Evol Biol. (2017 Nov)
Identification of Siglec Ligands Using a Proximity Labeling Method.
Chang L, Chen YJ, Fan CY, Tang CJ, Chen YH, Low PY, Ventura A, Lin CC, Chen YJ, Angata T.
J Proteome Res. (2017 Oct)
Graustein AD, Horne DJ, Fong JJ, Schwarz F, Mefford HC, Peterson GJ, Wells RD, Musvosvi M, Shey M, Hanekom WA, Hatherill M, Scriba TJ, Thuong NTT, Mai NTH, Caws M, Bang ND, Dunstan SJ, Thwaites GE, Varki A, Angata T, Hawn TR.
Tuberculosis (Edinb). (2017 May)
Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.
Ishii T, Angata T, Wan ES, Cho MH, Motegi T, Gao C, Ohtsubo K, Kitazume S, Gemma A, ParÉ PD, Lomas DA, Silverman EK, Taniguchi N, Kida K.
Respirology (2017 May)
Fong JJ, Sreedhara K, Deng L, Varki NM, Angata T, Liu Q, Nizet V, Varki A.
EMBO J. (2015 Nov)
[Review] Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.
Angata T, Nycholat CM, Macauley MS.
Trends Pharmacol Sci. (2015 Oct)
Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y, Takahata M, Mikuni S, Shimizu T, Hamano H, Angata T, Hatakeyama S, Kinjo M, Iwasaki N.
Bone. (2015 Feb)
[Review] Associations of genetic polymorphisms of Siglecs with human diseases.
Angata T.
Glycobiology. (2014 Sep)
Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease.
Angata T, Ishii T, Gao C, Ohtsubo K, Kitazume S, Gemma A, Kida K, Taniguchi N.
Physiol Rep. (2014 Jul)
Ali SR, Fong JJ, Carlin AF, Busch TD, Linden R, Angata T, Areschoug T, Parast M, Varki N, Murray J, Nizet V, Varki A.
J Exp Med. (2014 Jun)